Faron, M. http://orcid.org/0000-0003-2331-0792
Naman, A.
Delahousse, J.
Hescot, S.
Hadoux, J.
Castinetti, F.
Drui, D.
Renoult-Pierre, P.
Libe, R.
Lamartina, L.
Leboulleux, S.
Al-Ghuzlan, A.
Lombès, M.
Paci, A.
Baudin, E.
,
Article History
Received: 26 March 2024
Accepted: 3 August 2024
First Online: 22 August 2024
Declaration
:
: EB and RL: received honoraria from HRA Pharma.MF: received honoraria from VIFOR Pharma and travel grant from Novartis.LL: received honoraria from BAYER, EISAI, LILLY, IPSEN and ROCHE and travel grant from AAA Novartis.JH: received honoraria from BIARD.
: The local Ethics committee approved the study. This study complies with French law (Jarde type 3) for an observational study.
: Written informed consent was collected for each patient before inclusion.